'Her2 positive advanced bc' diaporamas de présentation

Bachelot T et al. Proc SABCS 2012;Abstract OT1-1-02. (Ongoing Trials Session)

A Single-Arm Phase IIIb Study of Pertuzumab and Trastuzumab with a Taxane as First-Line Therapy for Patients with HER2-Positive Advanced Breast Cancer (PERUSE). Bachelot T et al. Proc SABCS 2012;Abstract OT1-1-02. (Ongoing Trials Session). Background.

87 views • 8 slides